Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Merck & Co Inc (NYSE:MRK)

66.02
Delayed Data
As of 4:00pm ET
 +0.56 / +0.86%
Today’s Change
55.10
Today|||52-Week Range
66.80
+12.15%
Year-to-Date
Merck's Powerful Rally Is Coming So Back Up the Truck
1:50pm / TheStreet.com - Paid Partner Content
VBI Vaccines Just Took a Major Step Forward in Its HBV Program
Jun 21 / GuruFocus News - Paid Partner Content
Why You Should Add Novo Nordisk Stock to Your Portfolio
11:43am / Zacks.com - Paid Partner Content
Dems Roast Trump for Leaving Medicare Out of Drug Price Order
Jun 21 / TheStreet.com - Paid Partner Content
Glaxo's (GSK) Shingles Candidate Phase III Data Positive
10:51am / Zacks.com - Paid Partner Content
Novo Nordisk's Victoza Gets FDA Panel Nod for Label Expansion
Jun 21 / Zacks.com - Paid Partner Content
Merck's Keytruda on a Roll: Can it Retain the Momentum?
10:51am / Zacks.com - Paid Partner Content
Small Cancer Biotech Space in Focus, 3 Stocks Up 100% & More
Jun 21 / Zacks.com - Paid Partner Content
Ligand Gets Milestone Payment on Partner Drug FDA Approval
Jun 21 / Zacks.com - Paid Partner Content
Bristol-Myers Opdivo Positive in Phase II Study CheckMate-205
Jun 19 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close65.46
Today’s open65.51
Day’s range65.38 - 66.37
Volume12,585,456
Average volume (3 months)9,110,897
Market cap$179.0B
Dividend yield2.85%
Data as of 4:00pm ET, 06/22/2017

Growth & Valuation

Earnings growth (last year)-9.62%
Earnings growth (this year)+1.53%
Earnings growth (next 5 years)+6.20%
Revenue growth (last year)+1.86%
P/E ratio42.1
Price/Sales4.15
Price/Book4.49

Competitors

 Today’s
change
Today’s
% change
NVSNovartis+3.78+4.58%
PFEPfizer+0.18+0.53%
SNYSanofi+1.01+2.08%
ABBVAbbVie+1.84+2.58%
Data as of 4:02pm ET, 06/22/2017

Financials

Next reporting dateJuly 28, 2017
EPS forecast (this quarter)$0.88
Annual revenue (last year)$39.5B
Annual profit (last year)$3.9B
Net profit margin9.93%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman, President &
Chief Executive Officer
Kenneth C. Frazier
Chief Financial Officer &
Executive Vice President
Robert M. Davis
Corporate headquarters
Kenilworth, New Jersey

Forecasts